Results from NBIS Partner project among top ten important research news 2025

The result from the ALASCCA study, showing that that low-dose aspirin halves the risk of colorectal cancer relapsing after surgery, has been recognised as number 6 on the Dagens Medicin top ten leading research news in the world (link to the list, in Swedish). The results establish a new standard and the treatment has already initiated in Swedish clinics.

The system for analysis and reporting was established by Markus Mayrhofer in a NBIS Partner project with Johan Lindberg, KI. “The setup for analyzing the processed sequencing data and reporting to suit the ALASCCA trial that Markus established has worked amazingly well”. (See further here.)